中文

← All funding rounds

Relation Therapeutics

EuropeDrug discoveryLondon, United KingdomFounded 2020Private

Website · relationrx.com ↗

Finds drug targets by profiling patients' own tissue with single-cell and genetic data, then machine learning and lab tests; first in osteoporosis.

Disclosed total$86M
Rounds on record3
Latest round$26MRound (unnamed) · 2025-12-09
Last stated valuationNone stated
Investors named11
Research on recordNone yet

Money and evidence

Moneyeach round in US dollars; ≈ converted at its date2023202420252026$25M$35M$26M
Closed round

No research by this company is on the record yet.

Rounds and research, on one timeline

  1. 2025-12-09Round (unnamed)
    Round

    $26M

    Not stated

    Announced by lead investor DCVC alongside the Novartis deal; separate from the equity Novartis takes under that deal.

    Co-lead · DCVC ✓Co-lead · NVentures (NVIDIA) ✓Co-lead · Magnetic Ventures ✓

    On the deal: Jason Pontin (General Partner, DCVC, joins the board); Zachary Bogue (Co-founder and Managing Partner, DCVC)

    Announced by the company · dcvc.com ↗

  2. 2024-03-14Seed
    Round

    $35M

    For: moving its osteoporosis pipeline toward the clinic and new discovery campaigns

    Toward the clinic

    The release puts total seed funding at $60M; DCVC later wrote $80M over three seed rounds, so the two counts disagree.

    Co-lead · DCVC ✓Co-lead · NVentures (NVIDIA, co-lead) ✓Magnetic Ventures ✓Khosla VenturesARK InvestDeerfield ManagementJonathan Milner

    On the deal: Christine Aylward (Founder, Magnetic Ventures); Jason Pontin (General Partner, DCVC, joins the board); Jonathan Milner (Existing investor); Mohamed Siddeek (Corporate VP; head of NVentures, NVentures (NVIDIA, co-lead))

    Announced by the company · bioindustry.org ↗

  3. 2022-06Seed
    Round

    $25M

    For: scale its platform and advance therapeutic candidates

    Models and platform

    Use of funds from the company's release as reposted by BioSpace.

    Co-lead · DCVC ✓Co-lead · Magnetic Ventures ✓Khosla VenturesOMERS Venturesfirstminute Capital ✓Jonathan MilnerPeer SchatzMark Stevenson

    On the deal: Jonathan Milner (Angel investor); Mark Stevenson (Angel investor); Peer Schatz (Angel investor)

    The investor's own page says · firstminute Capital: date field 2024-06-01

    Reported by Cambridge Biocapital · cambridgebiocapital.substack.com ↗

Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.

See these rounds in the table →

On the investors' own sites

Investors that name this company on their own site, in a portfolio or their own announcement. A ✓ in a round marks the same investor.

Its investors also backed

Other companies on this page whose rounds name the same investor.